A Phase 1, Open-Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Single Dose, Crossover Study to Evaluate the Safety and Pharmacokinetics of Oral and Intravenous Administration of Methamphetamine Hydrochloride in Healthy Volunteers

Trial Profile

A Phase 1, Open-Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Single Dose, Crossover Study to Evaluate the Safety and Pharmacokinetics of Oral and Intravenous Administration of Methamphetamine Hydrochloride in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jul 2011

At a glance

  • Drugs Metamfetamine; Metamfetamine
  • Indications Brain injuries; Stroke
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Jul 2011 Status changed from recruiting to completed.
    • 11 Jul 2011 Added title (from MR) and treatment table. Amended purpose.
    • 14 Jun 2010 Status changed from planning to recruiting, based on a Sinapis Pharma media release. Dosing in the first cohort has been successful; future cohorts will investigate longer infusion times and higher dosages.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top